STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET

Company Participants

Joey Delahoussaye - Investor Relations
Dolev Rafaeli - Chief Executive Officer
Chris Lesovitz - Chief Financial Officer

Conference Call Participants

Operator

Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the STRATA Skin Sciences Inc. Second Quarter 2024 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask question. [Operator Instructions] Participants of this call are advised, that the audio of this conference call is being broadcast live over the internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call through February 14, 2025.

I would now like to turn the call over to Joey Delahoussaye of Core IR; the company’s Investor Relations firm. Please go ahead, sir.

Joey Delahoussaye

Thank you, Betsy [ph]. Good afternoon and thank you for participating in today's conference call. Earlier this afternoon, the company released its financial results for the quarter ended June 30, 2024. A copy of that press release can be found on the company's website at www.strataskinsciences.com under the Investors tab.

Joining me on today's earnings call from STRATA Skin Sciences Management Team are Dr. Dolev Rafaeli, Chief Executive Officer; and Chris Lesovitz, Chief Financial Officer. During this call, management will be making forward-looking statements, including statements that address STRATA Skin Sciences expectations for future performance or operational results. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in STRATA Skin Sciences most recently filed annual report and Form 10-K and subsequent periodic reports filed with the SEC and STRATA Skin Sciences press release that accompanies this call, particularly the cautionary statements in it. The content of this call contains time sensitive information that is accurate only as of today, August 14, 2024. Except as required by law STRATA Skin Sciences disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call.

It's now my pleasure to turn the call over to CEO, Dr. Dolev Rafaeli.

Dolev Rafaeli

Thanks, Joey and good afternoon to everyone on the call. During the second quarter, we made continued financial and strategic progress in turning our business around. Total revenue of $8.4 million grew 2% year-over-year. Total operating expenses declined approximately $860,000 or 14% year-over-year and our loss from operations declined by $1.5 million to roughly $500,000 from approximately $2.0 million last year.